Cafepharma Today

Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bioworld
Saturday, September 6, 2008 - 10:44am
tags:
Boston Globe, MA
Saturday, September 6, 2008 - 10:41am
tags:
Medical News Today
Saturday, September 6, 2008 - 10:34am
tags:
Forbes
Saturday, September 6, 2008 - 10:31am
tags:
Bloomberg
Friday, September 5, 2008 - 11:48am
tags:
Bizjournals.com
Friday, September 5, 2008 - 11:47am
tags:
Yahoo/AP
Friday, September 5, 2008 - 10:11am
tags:
Yahoo/TheStreet.com
Friday, September 5, 2008 - 9:08am
tags:
Forbes
Friday, September 5, 2008 - 9:07am
tags:
Pharmaceutical Business Review
Friday, September 5, 2008 - 9:04am
tags:
Yahoo/Businessweek
Friday, September 5, 2008 - 9:03am
tags:
Seeking Alpha
Friday, September 5, 2008 - 9:01am
tags:
Businessweek
Friday, September 5, 2008 - 8:59am
tags:
Star Ledger, NJ
Friday, September 5, 2008 - 8:56am
tags:
Pharmaceutical Business Review
Friday, September 5, 2008 - 8:54am
tags:
Yahoo/AP
Friday, September 5, 2008 - 8:53am
tags:
CNBC
Thursday, September 4, 2008 - 5:17pm
tags:
Yahoo/AP
Thursday, September 4, 2008 - 5:16pm
tags:
Yahoo/Real Money/TheStreet.com
Thursday, September 4, 2008 - 2:57pm
tags:

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.